REVIEW | |
1. | Atrial fibrillation, epidemiology and association with stroke Hakan Kültürsay Pages 1 - 6 |
2. | The trials of novel oral anticoagulants in non-valvular atrial fibrillation and their effect on the guidelines Burçak Kılıçkıran Avcı, Zeki Öngen Pages 7 - 13 |
3. | RE-LY study: subgroup analyses and reflections on clinical guidelines Murat Özdemir Pages 15 - 18 |
4. | Atrial fibrillation and stroke: secondary prophylaxis Birsen İnce Pages 19 - 24 |
5. | Use of dabigatran in patients with non-valvular atrial fibrillation: answers to frequently asked questions Onur Sinan Deveci, Mesut Demir, Mehmet Aksoy Pages 25 - 33 |
Copyright © 2024 Archives of the Turkish Society of Cardiology